Controversy over smoking in COVID‐19—A real world experience in New York city. Issue 7 (25th March 2021)

• Record Type: Journal Article
• Authors: Ho, Kam Sing; Narasimhan, Bharat; Sheehan, Jacqueline; Wu, LingLing; Fung, Jennifer Y.
• Other Names: Luo Guangxiang (George) guestEditor.; Ly Hinh guestEditor.; Gao Shou‐Jiang guestEditor.
• Is Part Of: Journal of medical virology. Volume 93:Issue 7(2021)
• Page Start: 4537
• Page End: 4543
• Publication Date: 2021-03-25
• Subjects: COVID‐19 infection -- hospitalization -- ICU admission -- mortality -- prevalence -- smoking; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.26738
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: Data are conflicting regarding the impact of tobacco smoking in people with pneumonia due to SARS‐CoV‐2 infection (COVID‐19). We performed a retrospective multicentre cohort study of 9991 consecutive patients hospitalized in a major New York academic center between March 7th and June 5th, 2020 with laboratory‐confirmed COVID‐19. The clinical outcomes assessed included risk of hospitalization, in‐hospital mortality, risk of intensive care unit (ICU) admission, and need for mechanical ventilation among smokers (current and former). Multivariable logistic regression and propensity score models were built to adjust for potential confounders. Among 9991 consecutive patients diagnosed with COVID‐19, 2212 (22.1%) patients were self‐reported smokers (406 current and 1806 former). Current smoking was not associated with an increased risk of hospitalization (propensity score [PS]‐adjusted OR 0.91; p = .46), in‐hospital mortality (PS‐OR 0.77; p = .12), ICU admission (PS‐OR 1.18; p = .37), or intubation (PS‐OR 1.04; p = .85). Similarly, former smoking was not associated with an increased risk of hospitalization (PS‐OR 0.88; p = .11), in‐hospital mortality (PS‐OR 1.03; p = .78), ICU admission (PS‐OR 1.03; p = .95), or intubation (PS‐OR 0.93; p = .57). Furthermore, smoking (current or former) was not associated with an increased risk of hospitalization (PS‐OR 0.85; p = .05), in‐hospital mortality (PS‐OR 0.94; p = .49), ICU admission (PS‐OR 0.86; p = .17), or intubation (PS‐OR 0.79; p = .06). Smoking is a well‐known risk factor associated with greater susceptibility and subsequent increased severity of respiratory infections. In the current COVID‐19 pandemic, smokers may have increased risk and severe pneumonia. In the current COVID‐19 pandemic, smokers are believed to have an increased risk of mortality as well as severe pneumonia. However, in our analysis of real‐world clinical data, smoking was not associated with increased in‐patient mortality in COVID‐19 pneumonia, in accordance with prior reports.